إعلان
إعلان
APLS
Apellis Pharmaceuticals, Inc. Common Stock
25.86
USDبرعاية
+0.74
+2.96%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
25.95
+0.09
+0.34%
تقارير أرباح APLS
النسبة الإيجابية المفاجئة
APLS تفوق 10 من 33 آخر التقديرات.
30%
التقرير التالي
بيانات التقرير القادم
٢٦ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$203.07M
/-$0.39
التغير الضمني من Q3 25 (Revenue/ EPS)
-55.72%
/-123.35%
التغير الضمني من Q4 24 (Revenue/ EPS)
-4.45%
/+39.29%
Apellis Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On ٣٠ أكتوبر ٢٠٢٥, APLS reported earnings of 1.67 USD per share (EPS) for Q3 25, beating the estimate of 1.20 USD, resulting in a 38.11% surprise. Revenue reached 458.58 مليون, compared to an expected 414.81 مليون, with a 10.55% difference. The market reacted with a -31.02% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 21 analysts forecast an EPS of -0.39 USD, with revenue projected to reach 203.07 مليون USD, implying an decrease of -123.35% EPS, and decrease of -55.72% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Apellis Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Apellis Pharmaceuticals, Inc. Common Stock reported EPS of $1.67, beating estimates by 38.11%, and revenue of $458.58M, 10.55% above expectations.
How did the market react to Apellis Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -31.02%, changed from $30.05 before the earnings release to $20.73 the day after.
When is Apellis Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٦ فبراير ٢٠٢٦.
What are the forecasts for Apellis Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 21
analysts, Apellis Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.39 and revenue of $203.07M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان